Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans [7]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 10, 2005, Pages 2357-2359

  Itakura, Haruka ^a   Telen, M J ^b   Hoppe, C C ^c   White, D A E ^d   Zehnder, J L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d ALAMEDA COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

AFRICAN AMERICAN; CARDIOVASCULAR RISK; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC RISK; GENOTYPE; HUMAN; INCIDENCE; LETTER; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VENOUS THROMBOEMBOLISM;

AFRICAN AMERICANS; HUMANS; POINT MUTATION; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 28444470812     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01562.x     Document Type: Letter

References (24)

1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-93.
2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O'Fallon WM, Melton LJ III. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
3. US Census Bureau. US Interim Projections by Age, Sex, Race, and Hispanic Origin 2004. US Census Bureau, 2004: http://www.census. gov/:pc/www/ usinterimproj/
4. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE study. J Thromb Haemost 2003; 1: 80-7.
5. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-40.
6. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
7. Stein PD, Patel KC, Kalra NK, El Baage TY, Savarapu P, Silbergleit A, Check FE. Deep venous thrombosis in a general hospital. Chest 2002; 122: 960-2.
8. Patel RK, Lambie J, Bonner L, Arya R. Venous thromboembolism in the black population. Arch Intern Med 2004; 164: 1348-9.
9. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90: 446-55.
10. McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen. J Natl Cancer Inst 2004; 96: 1762-9.
11. Araten DJ, Thaler HT, Luzzatto L. High incidence of thrombosis in African-American and Latin-American patients with paroxysmal nocturnal haemoglobinuria. Thromb Haemost 2005; 93: 88-91.
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
13. Rees DC. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996; 95: 579-86.
14. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.
15. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Gumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
16. Franco RF, Santos SE, Elion J, Tavella MH, Zago MA. Prevalence of the G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in different human populations. Acta Haematol 1998; 100: 9-12.
17. Warshawsky I, Hren C, Sercia L, Shadrach B, Deitcher SR, Newton E, Kottke-Marchant K. Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol 2002; 11: 152-6.
18. Schrijver I, Lenzi TJ, Jones CD, Lay MJ, Druzin ML, Zehnder JL. Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. J Mol Diagn 2003; 5: 250-3.
19. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003; 115: 721-8.
20. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004; 103: 2391-6.
21. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257-65.
22. Arya R. Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): pilot study in a black population in the United Kingdom. Thromb Haemost 2005; 93: 179-80.
23. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
24. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, Styles L. Distinct HLA. Associations by stroke subtype in children with sickle cell anemia. Blood 2003; 101: 2865-9.